Bloomberg Businessweek Weekend - June 28th, 2025
Bloomberg Businessweek
00:00
Gene Editing Breakthroughs and Challenges
This chapter explores significant advancements in gene editing, including in vivo editing to correct genetic diseases, while highlighting the declining venture capital interest in gene therapy. It also discusses the implications of innovative treatments, the complexities of costs, risks, and ethical dilemmas surrounding technologies like CRISPR.
Transcript
Play full episode
